These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 19734998

  • 1. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
    Zhong S, Yu D, Wang Y, Qiu S, Wu S, Liu XY.
    Acta Oncol; 2010; 49(1):91-9. PubMed ID: 19734998
    [Abstract] [Full Text] [Related]

  • 2. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
    Zhao L, Dong A, Gu J, Liu Z, Zhang Y, Zhang W, Wang Y, He L, Qian C, Qian Q, Liu X.
    Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
    [Abstract] [Full Text] [Related]

  • 3. Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil.
    Chu L, Gu J, Sun L, Qian Q, Qian C, Liu X.
    Gene Ther; 2008 Apr; 15(7):484-94. PubMed ID: 18239605
    [Abstract] [Full Text] [Related]

  • 4. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J, Wang Y, Qian Q, Qian C, Wu J, Liu XY.
    Cancer Res; 2006 Apr 15; 66(8):4291-8. PubMed ID: 16618754
    [Abstract] [Full Text] [Related]

  • 5. Synergistic antitumor effect of TRAIL and IL-24 with complete eradication of hepatoma in the CTGVT-DG strategy.
    Cai Y, Liu X, Huang W, Zhang K, Liu XY.
    Acta Biochim Biophys Sin (Shanghai); 2012 Jun 15; 44(6):535-43. PubMed ID: 22635106
    [Abstract] [Full Text] [Related]

  • 6. Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin.
    Ma B, Wang Y, Zhou X, Huang P, Zhang R, Liu T, Cui C, Liu X, Wang Y.
    J Cancer Res Clin Oncol; 2015 Mar 15; 141(3):419-29. PubMed ID: 25240826
    [Abstract] [Full Text] [Related]

  • 7. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
    Liu X, Cao X, Wei R, Cai Y, Li H, Gui J, Zhong D, Liu XY, Huang K.
    Cancer Gene Ther; 2012 Jan 15; 19(1):49-57. PubMed ID: 21979578
    [Abstract] [Full Text] [Related]

  • 8. VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis.
    Xiao T, Fan JK, Huang HL, Gu JF, Li LY, Liu XY.
    Cell Res; 2010 Mar 15; 20(3):367-78. PubMed ID: 19918267
    [Abstract] [Full Text] [Related]

  • 9. Targeting gene-virotherapy of cancer and its prosperity.
    Liu XY.
    Cell Res; 2006 Nov 15; 16(11):879-86. PubMed ID: 17102812
    [Abstract] [Full Text] [Related]

  • 10. Targeting gene-virotherapy of cancer.
    Liu XY, Gu JF.
    Cell Res; 2006 Jan 15; 16(1):25-30. PubMed ID: 16467873
    [Abstract] [Full Text] [Related]

  • 11. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q, Chen G, Peng L, Wang X, Yang Y, Liu C, Shi W, Su C, Wu H, Liu X, Wu M, Qian Q.
    Clin Cancer Res; 2006 Nov 01; 12(21):6523-31. PubMed ID: 17085667
    [Abstract] [Full Text] [Related]

  • 12. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis.
    Jiang G, Liu YQ, Wei ZP, Pei DS, Mao LJ, Zheng JN.
    Cancer Lett; 2010 Aug 28; 294(2):220-8. PubMed ID: 20189296
    [Abstract] [Full Text] [Related]

  • 13. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB, Wu CT, Wang H, Zhang QW, Wang L, Wang RL, Lu ZZ, Wang LS.
    Cancer Gene Ther; 2008 Mar 28; 15(3):173-82. PubMed ID: 18157145
    [Abstract] [Full Text] [Related]

  • 14. Enhanced sensitivity of hepatocellular carcinoma cells to chemotherapy with a Smac-armed oncolytic adenovirus.
    Pan QW, Zhong SY, Liu BS, Liu J, Cai R, Wang YG, Liu XY, Qian C.
    Acta Pharmacol Sin; 2007 Dec 28; 28(12):1996-2004. PubMed ID: 18031615
    [Abstract] [Full Text] [Related]

  • 15. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
    Ma S, Qu W, Mao L, Zhu Z, Jia L, Zhao L, Zheng X.
    Oncol Rep; 2012 May 28; 27(5):1443-50. PubMed ID: 22294034
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.
    Kondo N, Tsukuda M, Kimura M, Fujita K, Sakakibara A, Takahashi H, Ishiguro Y, Toth G, Matsuda H.
    Oncol Rep; 2010 Feb 28; 23(2):355-63. PubMed ID: 20043095
    [Abstract] [Full Text] [Related]

  • 17. Increased suppression of oncolytic adenovirus carrying mutant k5 on colorectal tumor.
    Fan JK, Xiao T, Gu JF, Wei N, He LF, Ding M, Liu XY.
    Biochem Biophys Res Commun; 2008 Sep 19; 374(2):198-203. PubMed ID: 18621025
    [Abstract] [Full Text] [Related]

  • 18. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy.
    Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY, Qian QJ, Liu XY.
    Cell Res; 2003 Dec 19; 13(6):481-9. PubMed ID: 14728805
    [Abstract] [Full Text] [Related]

  • 19. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E.
    Clin Cancer Res; 2007 Dec 01; 13(23):7155-65. PubMed ID: 18056196
    [Abstract] [Full Text] [Related]

  • 20. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
    Cafferata EG, Macció DR, Lopez MV, Viale DL, Carbone C, Mazzolini G, Podhajcer OL.
    Clin Cancer Res; 2009 May 01; 15(9):3037-49. PubMed ID: 19336523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.